Chronic Kidney Disease (CKD) affects 30 million Americans, with millions more at increased risk.
The Kidney Disease: Improving Global Outcomes (KDIGO) clinical practice guideline on the management of chronic kidney disease–mineral and bone disorder (CKD–MBD) is intended to assist the practitioner caring for adults and children with CKD stages 3–5, on chronic dialysis therapy, or with a kidney transplant. The guideline contains recommendations on evaluation and treatment for abnormalities of CKD–MBD.
The newly released 2017 update to these guidelines includes changes that are important for managed care professionals to consider when assessing treatment options for patients with CKD-MBD
Dr. Block, who was a member of the CKD-MBD KDIGO Update Work Group, will highlight potential implications of this update to patients and clinicians.